Agir Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-07-2024
- Paid Up Capital ₹ 0.10 M
as on 31-07-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.56 M
as on 31-07-2024
- Revenue %
(FY 2023)
- Profit -285.69%
(FY 2023)
- Ebitda -285.55%
(FY 2023)
- Net Worth -158.01%
(FY 2023)
- Total Assets 20960.66%
(FY 2023)
About Agir Lifesciences
The Corporate was formerly known as Vedelik Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.56 M.
Mahesh Sharma and Tapan Sharma serve as directors at the Company.
- CIN/LLPIN
U24100MP2019PTC048406
- Company No.
048406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Agir Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Sharma  | Director | 08-Nov-2022 | Current |
| Tapan Sharma | Director | 22-Apr-2019 | Current |
Financial Performance of Agir Lifesciences.
Agir Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 285.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 158.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agir Lifesciences?
In 2023, Agir Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rusoma Laboratories Private LimitedActive 46 years 5 monthsMahesh Sharma and Tapan Sharma are mutual person
- Rusoma Healthcare Private LimitedActive 3 years 3 months
Mahesh Sharma and Tapan Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 Feb 2023 | ₹2.56 M | Open |
How Many Employees Work at Agir Lifesciences?
Unlock and access historical data on people associated with Agir Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agir Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agir Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
